Eluminex Biosciences Exclusively ... - sg.finance.yahoo.com
2021-7-19u2002·u2002Exclusive Global Development and Commercialization Rights for Recombinant Human Collagen-Based Biosynthetic Cornea Clinical Stage Asset Has Potential for First Approved Biosynthetic Human Cornea Biosynthetic Cornea Designed to Address Significant Unmet Need in Global Demand for Corneal Grafts for the Treatment of Corneal Blindness Edward Holland, MD, Joins Eluminex's …
Get Price